IL-6 and VEGF enhance the phosphorylation of ERK1/2 and Ras activation, leading to the expression of oncogenic transcription factors like MAF, which is associated with MM cell proliferation and drug resistance [94,113]. Here, IL6 is linked to Miyoshi myopathy.